Beta Cell Replacement Innovative Grants

Funding Agency:
Juvenile Diabetes Research Foundation International

JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom and/or lead to a groundbreaking discovery. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and testable and the proposal must be focused with a welldefined goal that is achievable within the timeframe of the award. 

Deadline: Oct. 31, 2017

Agency Website

Eligibility Requirements

Proposals may be submitted by domestic and foreign non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government. Innovative (but not pilot and research tool) proposals from for-profit organizations will also be considered. Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent and have a faculty position or equivalent at a college, university, medical school, or other research facility. There are no citizenship requirements for this program. To assure continued excellence and diversity among applicants and awardees, JDRF welcomes proposals from all qualified individuals and encourages proposals from persons with disabilities, women, and members of minority groups underrepresented in the sciences. 



Amount Description

Innovative grants provide one year of support for a maximum of USD 100,000 in direct costs and indirect costs of 10%, for a total of USD 110,000. These grants are not renewable. A final progress report is due within 75 days following the close of the award. 

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 31, 2017